New drugs for peripheral T-cell lymphomas


Published: June 10, 2009
Abstract Views: 175
PDF: 275
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Over the past few years, considerable progress has been made in the treatment of patients with non-Hodgkin’s lymphomas (NHL), primarily those with B-cell malignancies. Unfortunately, however, the outcome of patients with peripheral T-cell lymphomas remains disappointing. Although responses can be achieved with intensive combination chemotherapy regimens, relapse is common and few successful salvage therapies are available.

Supporting Agencies


Cheson, B. (2009). New drugs for peripheral T-cell lymphomas. Hematology Meeting Reports (formerly Haematologica Reports), 2(13). https://doi.org/10.4081/hmr.v2i13.487

Downloads

Citations